CSBR vs KO · P/E 16, rev $56.9M vs P/E 25, rev $47.94B
Champions Oncology Inc (CSBR) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the CSBR and KO stock pages for the full models.
Not investment advice.